Why Is Marvell Stock Up?
Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…
Sell
10
HART Quote, Financials, Valuation and Earnings
Last price:
$31.05
Seasonality move
:
1.03%
Day range:
$31.16 - $31.17
52-week range:
$28.56 - $34.43
Dividend yield:
1.19%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
242
Avg. volume:
764
1-year change:
6.36%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HART
NYLI Healthy Hearts ETF
|
$31.17 | -- | -- | -- | $0.06 | 1.19% | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
$25.59 | -- | -- | -- | $0.10 | 0.4% | -- |
|
IXJ
iShares Global Healthcare ETF
|
$87.59 | -- | -- | -- | $0.62 | 1.47% | -- |
|
PPH
VanEck Pharmaceutical ETF
|
$87.07 | -- | -- | -- | $0.41 | 1.96% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HART
NYLI Healthy Hearts ETF
|
-- | 0.838 | -- | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | 0.555 | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | 1.012 | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | 0.807 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- | -- |
NYLI Healthy Hearts ETF vs. Competitors
-
Which has Higher Returns HART or IBRN?
iShares Neuroscience and Healthcare ETF has a net margin of -- compared to NYLI Healthy Hearts ETF's net margin of --. NYLI Healthy Hearts ETF's return on equity of -- beat iShares Neuroscience and Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HARTNYLI Healthy Hearts ETF-- -- -- IBRNiShares Neuroscience and Healthcare ETF-- -- -- -
What do Analysts Say About HART or IBRN?
NYLI Healthy Hearts ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Neuroscience and Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Healthy Hearts ETF has higher upside potential than iShares Neuroscience and Healthcare ETF, analysts believe NYLI Healthy Hearts ETF is more attractive than iShares Neuroscience and Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings HARTNYLI Healthy Hearts ETF0 0 0 IBRNiShares Neuroscience and Healthcare ETF0 0 0 -
Is HART or IBRN More Risky?
NYLI Healthy Hearts ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Neuroscience and Healthcare ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HART or IBRN?
NYLI Healthy Hearts ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.19%. iShares Neuroscience and Healthcare ETF offers a yield of 0.4% to investors and pays a quarterly dividend of $0.10 per share. NYLI Healthy Hearts ETF pays -- of its earnings as a dividend. iShares Neuroscience and Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HART or IBRN?
NYLI Healthy Hearts ETF quarterly revenues are --, which are smaller than iShares Neuroscience and Healthcare ETF quarterly revenues of --. NYLI Healthy Hearts ETF's net income of -- is lower than iShares Neuroscience and Healthcare ETF's net income of --. Notably, NYLI Healthy Hearts ETF's price-to-earnings ratio is -- while iShares Neuroscience and Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Healthy Hearts ETF is -- versus -- for iShares Neuroscience and Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HARTNYLI Healthy Hearts ETF-- -- -- -- IBRNiShares Neuroscience and Healthcare ETF-- -- -- --
-
Which has Higher Returns HART or IXJ?
iShares Global Healthcare ETF has a net margin of -- compared to NYLI Healthy Hearts ETF's net margin of --. NYLI Healthy Hearts ETF's return on equity of -- beat iShares Global Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HARTNYLI Healthy Hearts ETF-- -- -- IXJiShares Global Healthcare ETF-- -- -- -
What do Analysts Say About HART or IXJ?
NYLI Healthy Hearts ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Global Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Healthy Hearts ETF has higher upside potential than iShares Global Healthcare ETF, analysts believe NYLI Healthy Hearts ETF is more attractive than iShares Global Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings HARTNYLI Healthy Hearts ETF0 0 0 IXJiShares Global Healthcare ETF0 0 0 -
Is HART or IXJ More Risky?
NYLI Healthy Hearts ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Global Healthcare ETF has a beta of 0.680, suggesting its less volatile than the S&P 500 by 32.032%.
-
Which is a Better Dividend Stock HART or IXJ?
NYLI Healthy Hearts ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.19%. iShares Global Healthcare ETF offers a yield of 1.47% to investors and pays a quarterly dividend of $0.62 per share. NYLI Healthy Hearts ETF pays -- of its earnings as a dividend. iShares Global Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HART or IXJ?
NYLI Healthy Hearts ETF quarterly revenues are --, which are smaller than iShares Global Healthcare ETF quarterly revenues of --. NYLI Healthy Hearts ETF's net income of -- is lower than iShares Global Healthcare ETF's net income of --. Notably, NYLI Healthy Hearts ETF's price-to-earnings ratio is -- while iShares Global Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Healthy Hearts ETF is -- versus -- for iShares Global Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HARTNYLI Healthy Hearts ETF-- -- -- -- IXJiShares Global Healthcare ETF-- -- -- --
-
Which has Higher Returns HART or PPH?
VanEck Pharmaceutical ETF has a net margin of -- compared to NYLI Healthy Hearts ETF's net margin of --. NYLI Healthy Hearts ETF's return on equity of -- beat VanEck Pharmaceutical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HARTNYLI Healthy Hearts ETF-- -- -- PPHVanEck Pharmaceutical ETF-- -- -- -
What do Analysts Say About HART or PPH?
NYLI Healthy Hearts ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Pharmaceutical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Healthy Hearts ETF has higher upside potential than VanEck Pharmaceutical ETF, analysts believe NYLI Healthy Hearts ETF is more attractive than VanEck Pharmaceutical ETF.
Company Buy Ratings Hold Ratings Sell Ratings HARTNYLI Healthy Hearts ETF0 0 0 PPHVanEck Pharmaceutical ETF0 0 0 -
Is HART or PPH More Risky?
NYLI Healthy Hearts ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VanEck Pharmaceutical ETF has a beta of 0.669, suggesting its less volatile than the S&P 500 by 33.103%.
-
Which is a Better Dividend Stock HART or PPH?
NYLI Healthy Hearts ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.19%. VanEck Pharmaceutical ETF offers a yield of 1.96% to investors and pays a quarterly dividend of $0.41 per share. NYLI Healthy Hearts ETF pays -- of its earnings as a dividend. VanEck Pharmaceutical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HART or PPH?
NYLI Healthy Hearts ETF quarterly revenues are --, which are smaller than VanEck Pharmaceutical ETF quarterly revenues of --. NYLI Healthy Hearts ETF's net income of -- is lower than VanEck Pharmaceutical ETF's net income of --. Notably, NYLI Healthy Hearts ETF's price-to-earnings ratio is -- while VanEck Pharmaceutical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Healthy Hearts ETF is -- versus -- for VanEck Pharmaceutical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HARTNYLI Healthy Hearts ETF-- -- -- -- PPHVanEck Pharmaceutical ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is General Electric Stock Going Up?
General Electric Company, doing business these days as GE Aerospace…
Where Will Cisco Systems Stock Be in 10 Years?
Cisco Systems, Inc. (NASDAQ:CSCO) has enjoyed its position as a…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
44
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
1
IONQ alert for Jan 9
IonQ [IONQ] is down 38.82% over the past day.
Sell
40
QMCO alert for Jan 9
Quantum [QMCO] is down 30.08% over the past day.
Sell
47
MATW alert for Jan 9
Matthews International [MATW] is up 14.21% over the past day.
